BT

Benny Thomas

Active Director Cfo DIN 07241561
DIN 07241561 First appointment Jul 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Jul 2015
Shareholding value •••• Premium profile

About Benny Thomas

Data last updated:

Benny Thomas is a Cfo at Sami-Sabinsa Group Limited (since 2025) and Cfo at Sami Nutraceuticals Private Limited (since 2025). The companies operate in Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1,155 Cr; the largest is Sami-Sabinsa Group Limited at ₹1,137 Cr (FY 2025). Earlier, Benny Thomas was a Director at Jubilant Clinsys Limited (2015–2025) and Cfo at Jubilant Biosys Limited (2017–2025) and 3 more.

DIN 07241561
Primary Designation Cfo
Industry Healthcare
First Appointment 29 Jul 2015
Oldest Company Age 35 yrs
Largest company Sami-Sabinsa Group Limited · ₹1,137 Cr (FY 2025)
Combined revenue ₹1,155 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sami-Sabinsa Group Limited U68100KA1991PLC011880
Cfo01 Dec 20251991₹1,137 Cr (FY 2025)Active
Sami Nutraceuticals Private Limited U15490KA2020PTC133889
Cfo01 Dec 20252020₹18.00 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jubilant Clinsys Limited U24232UP2004PLC029008
Director29 Jul 20152004₹15.5 Lakh (FY 2022)Active
Jubilant Biosys Limited U24110UP1998PLC029591
Cfo20 Mar 20171998₹563 Cr (FY 2023)Active
Jubilant Chemsys Limited U24232UP2004PLC029009
Director28 Mar 20182004₹126 Cr (FY 2019)Amalgamated
Jubilant Innovation (India) Limited U73100UP2007PLC034211
Director29 Jan 20162007₹49,000 (FY 2018)Dissolved (Liquidated)
Director28 Mar 20182009₹29.5 Lakh (FY 2018)Dissolved (Liquidated)

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jubilant Innovation (India) Limited
Vanthys Pharmaceutical Development Private Limited
Sami-Sabinsa Group Limited
Sami Nutraceuticals Private Limited
Premium access

Shareholding and investment profile for Benny Thomas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Benny Thomas

Benny Thomas currently holds 2 directorships: Sami-Sabinsa Group Limited (Cfo, since 01 Dec 2025, revenue ₹1,137 Cr (FY 2025)); Sami Nutraceuticals Private Limited (Cfo, since 01 Dec 2025, revenue ₹18.00 Cr (FY 2025)).

Benny Thomas was first appointed on 29 Jul 2015 as Director at Jubilant Clinsys Limited. The most recent appointment on record is 01 Dec 2025 at Sami Nutraceuticals Private Limited.

The 2 current companies of Benny Thomas that report revenue have a combined latest revenue of ₹1,155 Cr: Sami-Sabinsa Group Limited ₹1,137 Cr (FY 2025); Sami Nutraceuticals Private Limited ₹18.00 Cr (FY 2025).

Benny Thomas held 5 earlier board appointments: Jubilant Clinsys Limited (Director, 29 Jul 2015 to 28 Oct 2025); Jubilant Biosys Limited (Cfo, 20 Mar 2017 to 30 Jun 2025); Jubilant Chemsys Limited (Director, 28 Mar 2018 to 29 Oct 2018); Jubilant Innovation (India) Limited (Director, from 29 Jan 2016); Vanthys Pharmaceutical Development Private Limited (Director, from 28 Mar 2018).

The current boards of Benny Thomas's companies include Anju Majeed (Sami-Sabinsa Group Limited), Kasaragod Ullas Kamath (Sami-Sabinsa Group Limited), Kemal Pasha Bathisha (Sami-Sabinsa Group Limited), Madhu Subramanian (Sami-Sabinsa Group Limited), Nagarajan Muthukaman (Sami-Sabinsa Group Limited), Shaheen Muhammed Majeed (Sami-Sabinsa Group Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available